Continuous Risk Score Predicts Waitlist and Post-Transplant Outcomes in HCC

Arndt Vogel shared on X:

“Continuous Risk Score Predicts Waitlist and Post-Transplant Outcomes in HCC Despite

Exception Changes HALT-HCC: MELD-Na, Tumor burden score (max tumor diameter and number, AFP HALT-HCC predicts waitlist dropout and post-transplant survival.”

Read further.
Source: Arndt Vogel/X

Arndt Vogel, MD, is a Managing Senior Consultant and a Professor in the Department of Gastroenterology, Hepatology, and Endocrinology at Hannover Medical School. Leading the GI-Cancer Center and the Center for Personalized Medicine, his research focuses on translational and clinical studies in gastrointestinal cancer. He’s actively engaged in various societies including ESMO, ASCO, and EASL. Additionally, he chairs the Hepatobiliary Cancer Study Group of the AIO, contributing significantly to clinical oncology in Germany. Within ESMO, he serves on the Guidelines Steering Committee.